Cargando…

Common osteoporosis drug associated with increased rates of depression and anxiety

Osteoporosis affects over 10 million Americans over 50. Bisphosphonate therapy, mainly alendronate, is amongst the most prescribed treatments for the disease. The use of alendronate and other bisphosphonates has been associated with depressive symptoms in recent case reports. In this study we quanti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keshishi, Dro, Makunts, Tigran, Abagyan, Ruben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671447/ https://www.ncbi.nlm.nih.gov/pubmed/34907232 http://dx.doi.org/10.1038/s41598-021-03214-x

Ejemplares similares

Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database
por: Cohen, Isaac V., et al.
Publicado: (2021)

How can proton pump inhibitors damage central and peripheral nervous systems?
por: Makunts, Tigran, et al.
Publicado: (2020)

Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety
por: Wollmer, M. Axel, et al.
Publicado: (2021)

Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis
por: Makunts, Tigran, et al.
Publicado: (2019)

Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data
por: Joulfayan, Haroutyun, et al.
Publicado: (2023)

Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids
por: Makunts, Tigran, et al.
Publicado: (2019)

Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports
por: Cohen, Isaac V., et al.
Publicado: (2020)

Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites
por: Makunts, Tigran, et al.
Publicado: (2020)

Retrospective analysis of clinical trial safety data for pembrolizumab reveals the effect of co-occurring infections on immune-related adverse events
por: Makunts, Tigran, et al.
Publicado: (2022)

Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
por: Cohen, Isaac V., et al.
Publicado: (2017)

Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory
por: Makunts, Tigran, et al.
Publicado: (2019)

Publisher Correction: Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
por: Cohen, Isaac V., et al.
Publicado: (2017)

Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database
por: Makunts, Tigran, et al.
Publicado: (2022)

Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system
por: Makunts, Tigran, et al.
Publicado: (2023)

Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain
por: Makunts, Tigran, et al.
Publicado: (2018)

Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data
por: Makunts, Tigran, et al.
Publicado: (2021)

Diverticular disease is associated with an increased incidence rate of depression and anxiety disorders
por: Loosen, Sven H., et al.
Publicado: (2021)

COVID-19 Is Associated With an Increase in Visits for Anxiety but Not Depression
por: Pfoh, Elizabeth, et al.
Publicado: (2021)

Association between common cardiovascular drugs and depression
por: Tao, Shu-Hui, et al.
Publicado: (2021)

A Possible Role of Anhedonia as Common Substrate for Depression and Anxiety
por: Grillo, Luigi
Publicado: (2016)

Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system
por: Xiao, Yao, et al.
Publicado: (2023)

Analysis of drug binding pockets and repurposing opportunities for twelve essential enzymes of ESKAPE pathogens
por: Naz, Sadia, et al.
Publicado: (2017)

Brazil: world leader in anxiety and depression rates
por: de Souza, Ildebrando Moraes, et al.
Publicado: (2017)

Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety Disorders
por: Gairing, Simon Johannes, et al.
Publicado: (2021)

Common Polymorphism in the LRP5 Gene May Increase the Risk of Bone Fracture and Osteoporosis
por: Xu, Guang-Yue, et al.
Publicado: (2014)

Anxiety, Depression, and Common Chronic Diseases, and Their Association With Social Determinants in Saudi Primary Care
por: Baghdadi, Leena R., et al.
Publicado: (2021)

Increasing digitalization is associated with anxiety and depression: A Google Ngram analysis
por: Teepe, Gisbert Wilhelm, et al.
Publicado: (2023)

Rates of depression, anxiety, and stress in parents of children with congenital heart disease using the Depression Anxiety Stress Scale
por: Lee, Brian K., et al.
Publicado: (2022)

Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS)
por: Covic, Tanya, et al.
Publicado: (2012)

The relationship between osteoporosis and depression
por: Kashfi, Seyyed Sadra, et al.
Publicado: (2022)

53 Continued Resident Depression, Anxiety and Stress Despite Declining Covid Numbers and Increasing Vaccination Rates
por: Espinosa, C., et al.
Publicado: (2021)

Validation of geriatric depression and anxiety rating scales into Arabic
por: Karam, Georges Elie, et al.
Publicado: (2018)

Anxiety and depression in rheumatoid arthritis patients: prevalence, risk factors and consistency between the Hospital Anxiety and Depression Scale and Zung’s Self-rating Anxiety Scale/Depression Scale
por: Cheng, Lu, et al.
Publicado: (2023)

Match-Only Integral Distribution (MOID) Algorithm for high-density oligonucleotide array analysis
por: Zhou, Yingyao, et al.
Publicado: (2002)

ICD‐11 ‘mixed depressive and anxiety disorder’ is clinical rather than sub‐clinical and more common than anxiety and depression in the general population
por: Shevlin, Mark, et al.
Publicado: (2021)

Is Conception by Means In Vitro Fertilization Associated With Increased Risk of Antenatal Anxiety and Depression?
por: Arvanitidou, Olga, et al.
Publicado: (2023)

Common mechanisms and holistic care in atherosclerosis and osteoporosis
por: Szekanecz, Zoltán, et al.
Publicado: (2019)

Influence of Insurance Benefit Criteria on the Administration Rate of Osteoporosis Drugs in Postmenopausal Females
por: Lee, Jae Hyup, et al.
Publicado: (2014)

Depression and Anxiety Mediate the Association between Sleep Quality and Self-Rated Health in Healthcare Students
por: Zhu, Yihong, et al.
Publicado: (2023)

Associations between Self-Rated Health and Perinatal Depressive and Anxiety Symptoms among Latina Women
por: Juarez Padilla, Janeth, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qo4gajbhnsiro2pol8k81g0qmg